Stay updated with breaking news from Integrated Addendum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration (FDA) has announced this month (June) it is requesting feedback on draft recommendations and how they should be applied to increasingly diverse trial types and data sources.
The FDA has announced it is taking additional steps to modernize clinical trials, and is requesting feedback on draft recommendations, and how they should be applied to increasingly diverse trial types and data sources, according to a June 6 news release issued by the agency.
The FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials.
On March 15, the U.S. Food and Drug Administration (FDA) issued revised draft guidance summarizing how it intends regulate the use of electronic…
On March 15, the U.S. Food and Drug Administration (FDA) issued revised draft guidance summarizing how it intends regulate the use of electronic systems, records, and signatures in...